Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 361 to 375 of 888 results for community guidance

  1. Community-based multidisciplinary pelvic floor dysfunction teams: What roles are needed in a community-based multidisciplinary pelvic floor dysfunction team?

    NG210/21 Question Community-based multidisciplinary pelvic floor dysfunction teams: What roles are needed in a...

    Research recommendation
    Published
    7 January 2022

  2. Board, executive team and senior leaders interests register

    Outside interests of the NICE board

  3. What factors are necessary for an effective and cost effective community-wide approach to obesity prevention?

    Question What factors are necessary for an effective and cost effective community-wide approach to obesity prevention? Any explanatory...

    Research recommendation
    Published
    9 June 2015

  4. Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic assessment and intervention for people living with high levels of multimorbidity?

    Question Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic...

    Research recommendation
    Published
    18 October 2016

  5. Developing and updating local formularies (MPG1)

    This guideline covers good practice for developing and updating local formularies in line with statutory requirements. It supports developing formularies that reflect local needs, reduce variation in prescribing, and allow rapid adoption of new medicines and treatments.

    Medicines practice guideline
    Last updated
    28 October 2015
    View recommendations

    Sections for MPG1

  6. Bipolar disorder: assessment and management (CG185)

    This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.

    Clinical guideline
    Last updated
    2 September 2025
    View recommendations

    Sections for CG185

  7. Pancreatic cancer (QS177)

    This quality standard covers diagnosis of pancreatic cancer and management of pancreatic ductal adenocarcinoma in adults aged over 18. This quality standard describes high-quality care in priority areas for improvement. It does not cover national initiatives, such as cancer screening or audit.

    Quality standard
    Published
    20 December 2018
    View quality statements

    Sections for QS177

  8. Managing breakthrough pain:- What is the acceptability, safety, and effectiveness of different types of opioid analgesia for breakthrough pain in children and young people with life-limiting conditions who are having end of life care in the community?

    people with life-limiting conditions who are having end of life care in the community? Any explanatory notes(if applicable) Why this is...

    Research recommendation
    Published
    15 February 2017

  9. Social media:- How effective are online social media and networks at improving health and wellbeing and reducing health inequalities when they are used:- as a method of community engagement?- to support an existing community engagement approach?

    inequalities when they are used:- as a method of community engagement?- to support an existing community engagement...

    Research recommendation
    Published
    7 April 2016

  10. Diuretic therapy for managing fluid overload in people with advanced heart failure in the community:-  In people with advanced heart failure and significant peripheral fluid overload, what is the clinical and cost effectiveness of oral, subcutaneous and intravenous diuretic therapy in the community?

    for managing fluid overload in people with advanced heart failure in the community:- In people with advanced heart failure and...

    Research recommendation
    Published
    17 December 2018

  11. For people with moderate and severe alcohol dependence who have significant comorbid problems, is an intensive residential rehabilitation programme clinically and cost effective when compared with intensive community-based care?

    rehabilitation programme clinically and cost effective when compared with intensive community-based care? Any explanatory notes(if...

    Research recommendation
    Published
    9 June 2015

  12. Care and support for people with dementia:- What is the effect of specific interventions to support people with dementia during transition between inpatient mental health settings and community or care home settings?

    dementia during transition between inpatient mental health settings and community or care home settings? Any explanatory notes(if...

    Research recommendation
    Published
    17 October 2016

  13. Extended access to social care services:- What is the clinical and cost effectiveness of providing extended access to social care services, for example during early mornings and evenings, and 7 days a week?

    weekends, collaboration and multidisciplinary planning between hospital,community health services and social care is difficult to...

    Research recommendation
    Published
    15 November 2018

  14. Depression in adults: treatment and management (NG222)

    This guideline covers identifying, treating and managing depression in people aged 18 and over. It recommends treatments for first episodes of depression and further-line treatments, and provides advice on preventing relapse, and managing chronic depression, psychotic depression and depression with a coexisting diagnosis of personality disorder.

    NICE guideline
    Published
    29 June 2022
    View recommendations

    Sections for NG222

  15. Vascular access devices: skin decontamination:- What is the clinical and cost effectiveness of 2% chlorhexidine in alcohol versus 0.5% chlorhexidine in alcohol versus 2% chlorhexidine aqueous solution versus 0.5% chlorhexidine aqueous solution for cleansing skin (before insertion of peripheral vascular access devices [VADs] and during dressing changes of all VADs) in reducing VAD-related bacteraemia and VAD site infections?

    management of VADs is important for reducing phlebitis and bacteraemia. In the community, compliance is improved when a single solution...

    Research recommendation
    Published
    9 June 2015